1.北京中医药大学,北京 100029
2.中国中医科学院西苑医院内分泌科,北京 100091
杨茜,女,26岁,硕士研究生。研究方向:中医药防治内分泌代谢疾病。
黄珂,E-mail:15910737792@163.com
收稿:2024-12-22,
纸质出版:2025-12-25
移动端阅览
杨茜,郭腾,张广德,等.魏子孝从火蕴气郁内亏论治亚急性甲状腺炎[J].北京中医药,2025,44(12):1585-1589.
YANG Xi,GUO Teng,ZHANG Guangde,et al.WEI Zixiao's differentiation and treatment of subacute thyroiditis based on the theory of internal deficiency of fire-embedded qi stagnation[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(12):1585-1589.
杨茜,郭腾,张广德,等.魏子孝从火蕴气郁内亏论治亚急性甲状腺炎[J].北京中医药,2025,44(12):1585-1589. DOI: 10.16025/j.1674-1307.2025.12.015.
YANG Xi,GUO Teng,ZHANG Guangde,et al.WEI Zixiao's differentiation and treatment of subacute thyroiditis based on the theory of internal deficiency of fire-embedded qi stagnation[J]. Beijing Journal of Traditional Chinese Medicine,2025,44(12):1585-1589. DOI: 10.16025/j.1674-1307.2025.12.015.
亚急性甲状腺炎(SAT)是一种自限性甲状腺疾病。魏子孝教授基于多年临床实践,提出“火蕴气郁内亏”为本病核心病机,强调正气亏虚为发病之本,火毒内蕴为致病关键,气机郁滞贯穿病程始终。其主张分期论治,急性期以“实火”为主,治以清热解毒降实火;缓解期及恢复期以“虚火”为要,注重调和肝脾散郁火、匡扶正气防病复。辨治以脏腑为纲、虚实相参,强调肝脾同调、气血并治,辅以化痰活血、散结消肿,形成“扶正祛邪并重、分期动态施治”的辨治体系,临床疗效显著,为中医药防治SAT提供了思路。
Subacute thyroiditis (SAT) is a self-limiting thyroid disorder. Based on years of clinical practice, Professor WEI Zixiao proposes that the core pathogenesis of SAT is "internal deficiency with fire-embedded qi stagnation", emphasizing that deficiency of healthy
qi
is the fundamental root of the disease, internal accumulation of fire-toxin is the key pathogenic factor, and
qi
stagnation persists throughout the disease course. He advocates stage-specific treatment. Specifically, during the acute phase, characterized by excess fire, therapy focuses on clearing heat, eliminating toxins, and reducing excess fire. During the remission and recovery phases, dominated by deficiency fire, treatment emphasizes regulating the liver and spleen to disperse fire and strengthening healthy
qi
to prevent recurrence. Syndro
me differentiation and treatment are guided by the
Zang-fu
organs and integrate assessments of deficiency and excess, emphasizing simultaneous regulation of the liver and spleen and combined treatment of
qi
and blood, supplemented by resolving phlegm, activating blood circulation, dissipating nodules, and reducing swelling. This forms a therapeutic system of "reinforcing healthy
qi
while eliminating pathogenic factors, with stage-specific and dynamic treatment", which demonstrates remarkable clinical efficacy and provides a framework for the prevention and treatment of SAT with traditional Chinese medicine.
WIERSINGA WM , POPPE KG , EFFRAIMIDIS G . Hyperthyroidism: aetiology, pathogenesis, diagnosis, management, complications, and prognosis [J ] . Lancet Diabetes Endocrinol , 2023 , 11 ( 4 ): 282 - 298 .
ZHANG J , DING G , LI J , et al . Risk factors for subacute thyroiditis recurrence: a systematic review and meta-analysis of cohort studies [J ] . Front Endocrinol (Lausanne) , 2021 , 12 : 783439 .
STASIAK M , LEWIńSKI A . New aspects in the pathogenesis and management of subacute thyroiditis [J ] . Rev Endocr Metab Disord , 2021 , 22 ( 4 ): 1027 - 1039 .
RAY I , D'SOUZA B , SARKER P , et al . Management of subacute thyroiditis - a systematic review of current treatment protocols [J ] . Int J Gen Med , 2022 , 15 : 6425 - 6439 .
YUAN A , WU J , HUANG H . Comparison of treatment outcome between glucocorticoids and non-steroidal anti-inflammatory drugs in subacute thyroiditis patients-a systematic review and meta-analysis [J ] . Front Endocrinol (Lausanne) , 2024 , 15 : 1384365 .
张翠 , 裴琴 , 刘恒 , 等 . 中医治疗亚急性甲状腺炎的临床研究进展 [J ] . 湖北中医杂志 , 2022 , 44 ( 5 ): 63 - 66 .
黄岚 , 陈碧莲 , 罗镭 . 白花蛇舌草的化学成分、药理作用及临床应用研究进展 [J ] . 中国药事 , 2023 , 37 ( 12 ): 1451 - 1460 .
陈斯 . 延胡索化学成分和药理作用研究进展 [J ] . 中医药信息 , 2021 , 38 ( 7 ): 78 - 82 .
王倩 , 周改莲 , 周文良 , 等 . 蜂房的研究进展及其质量标志物预测分析 [J ] . 中华中医药学刊 , 2021 , 39 ( 1 ): 254 - 258 .
李葆林 , 杨梦婷 , 支雅婧 , 等 . 徐长卿化学成分和药理作用的研究进展及质量标志物(Q-Marker)预测分析 [J ] . 中草药 , 2021 , 52 ( 12 ): 3725 - 3735 .
0
浏览量
0
下载量
0
CSCD
关联资源
相关文章
相关作者
相关机构
京公网安备 11010102006710号